位置:首页 > 蛋白库 > ATR_DROME
ATR_DROME
ID   ATR_DROME               Reviewed;        2517 AA.
AC   Q9VXG8; Q24135;
DT   07-MAR-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 2.
DT   03-AUG-2022, entry version 165.
DE   RecName: Full=Serine/threonine-protein kinase ATR;
DE            EC=2.7.11.1;
DE   AltName: Full=Ataxia telangiectasia and Rad3-related protein homolog;
DE            Short=ATR homolog;
DE            Short=dATR;
DE   AltName: Full=Meiotic protein 41;
GN   Name=mei-41; ORFNames=CG4252;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota;
OC   Neoptera; Endopterygota; Diptera; Brachycera; Muscomorpha; Ephydroidea;
OC   Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND FUNCTION.
RX   PubMed=7671309; DOI=10.1016/0092-8674(95)90478-6;
RA   Hari K.L., Santerre A., Sekelsky J.J., McKim K.S., Boyd J.B., Hawley R.S.;
RT   "The mei-41 gene of D. melanogaster is a structural and functional homolog
RT   of the human ataxia telangiectasia gene.";
RL   Cell 82:815-821(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND INTERACTION WITH MUS304.
RX   PubMed=14729967; DOI=10.1128/mcb.24.3.1219-1231.2004;
RA   Brodsky M.H., Weinert B.T., Tsang G., Rong Y.S., McGinnis N.M., Golic K.G.,
RA   Rio D.C., Rubin G.M.;
RT   "Drosophila melanogaster MNK/Chk2 and p53 regulate multiple DNA repair and
RT   apoptotic pathways following DNA damage.";
RL   Mol. Cell. Biol. 24:1219-1231(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X., Brandon R.C.,
RA   Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D., Wan K.H., Doyle C.,
RA   Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G., Abril J.F., Agbayani A.,
RA   An H.-J., Andrews-Pfannkoch C., Baldwin D., Ballew R.M., Basu A.,
RA   Baxendale J., Bayraktaroglu L., Beasley E.M., Beeson K.Y., Benos P.V.,
RA   Berman B.P., Bhandari D., Bolshakov S., Borkova D., Botchan M.R., Bouck J.,
RA   Brokstein P., Brottier P., Burtis K.C., Busam D.A., Butler H., Cadieu E.,
RA   Center A., Chandra I., Cherry J.M., Cawley S., Dahlke C., Davenport L.B.,
RA   Davies P., de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I.,
RA   Dietz S.M., Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C.,
RA   Dunn P., Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S.,
RA   Fleischmann W., Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M.,
RA   Glasser K., Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J., Hostin D.,
RA   Houston K.A., Howland T.J., Wei M.-H., Ibegwam C., Jalali M., Kalush F.,
RA   Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A., Kimmel B.E., Kodira C.D.,
RA   Kraft C.L., Kravitz S., Kulp D., Lai Z., Lasko P., Lei Y., Levitsky A.A.,
RA   Li J.H., Li Z., Liang Y., Lin X., Liu X., Mattei B., McIntosh T.C.,
RA   McLeod M.P., McPherson D., Merkulov G., Milshina N.V., Mobarry C.,
RA   Morris J., Moshrefi A., Mount S.M., Moy M., Murphy B., Murphy L.,
RA   Muzny D.M., Nelson D.L., Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R.,
RA   Pacleb J.M., Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V.,
RA   Reese M.G., Reinert K., Remington K., Saunders R.D.C., Scheeler F.,
RA   Shen H., Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E., Svirskas R.,
RA   Tector C., Turner R., Venter E., Wang A.H., Wang X., Wang Z.-Y.,
RA   Wassarman D.A., Weinstock G.M., Weissenbach J., Williams S.M., Woodage T.,
RA   Worley K.C., Wu D., Yang S., Yao Q.A., Ye J., Yeh R.-F., Zaveri J.S.,
RA   Zhan M., Zhang G., Zhao Q., Zheng L., Zheng X.H., Zhong F.N., Zhong W.,
RA   Zhou X., Zhu S.C., Zhu X., Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M.,
RA   Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [4]
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q., Stapleton M.,
RA   Yamada C., Ashburner M., Gelbart W.M., Rubin G.M., Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a systematic
RT   review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [5]
RP   FUNCTION, AND DEVELOPMENTAL STAGE.
RX   PubMed=10209095; DOI=10.1016/s0960-9822(99)80138-9;
RA   Sibon O.C.M., Laurencon A., Hawley R., Theurkauf W.E.;
RT   "The Drosophila ATM homologue Mei-41 has an essential checkpoint function
RT   at the midblastula transition.";
RL   Curr. Biol. 9:302-312(1999).
RN   [6]
RP   FUNCTION.
RX   PubMed=11676920; DOI=10.1016/s0960-9822(01)00483-3;
RA   Garner M., van Kreeveld S., Su T.T.;
RT   "mei-41 and bub1 block mitosis at two distinct steps in response to
RT   incomplete DNA replication in Drosophila embryos.";
RL   Curr. Biol. 11:1595-1599(2001).
RN   [7]
RP   FUNCTION.
RX   PubMed=12361566; DOI=10.1016/s0960-9822(02)01165-x;
RA   Abdu U., Brodsky M., Schuepbach T.;
RT   "Activation of a meiotic checkpoint during Drosophila oogenesis regulates
RT   the translation of Gurken through Chk2/Mnk.";
RL   Curr. Biol. 12:1645-1651(2002).
RN   [8]
RP   FUNCTION.
RX   PubMed=12689597; DOI=10.1016/s1534-5807(03)00085-6;
RA   Zhou L., Steller H.;
RT   "Distinct pathways mediate UV-induced apoptosis in Drosophila embryos.";
RL   Dev. Cell 4:599-605(2003).
RN   [9]
RP   MUTAGENESIS OF TRP-253; ALA-647; SER-810; THR-815; LEU-818; HIS-2032 AND
RP   PRO-2322.
RX   PubMed=12807779; DOI=10.1093/genetics/164.2.589;
RA   Laurencon A., Purdy A., Sekelsky J., Hawley R.S., Su T.T.;
RT   "Phenotypic analysis of separation-of-function alleles of MEI-41,
RT   Drosophila ATM/ATR.";
RL   Genetics 164:589-601(2003).
RN   [10]
RP   FUNCTION.
RX   PubMed=14711410; DOI=10.1016/j.cub.2003.12.032;
RA   Jaklevic B.R., Su T.T.;
RT   "Relative contribution of DNA repair, cell cycle checkpoints, and cell
RT   death to survival after DNA damage in Drosophila larvae.";
RL   Curr. Biol. 14:23-32(2004).
RN   [11]
RP   PHOSPHORYLATION OF GRP.
RX   PubMed=15860729; DOI=10.1242/jcs.02309;
RA   de Vries H.I., Uyetake L., Lemstra W., Brunsting J.F., Su T.T.,
RA   Kampinga H.H., Sibon O.C.M.;
RT   "Grp/DChk1 is required for G2-M checkpoint activation in Drosophila S2
RT   cells, whereas Dmnk/DChk2 is dispensable.";
RL   J. Cell Sci. 118:1833-1842(2005).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1569; TYR-1570; SER-1573 AND
RP   THR-1575, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Embryo;
RX   PubMed=18327897; DOI=10.1021/pr700696a;
RA   Zhai B., Villen J., Beausoleil S.A., Mintseris J., Gygi S.P.;
RT   "Phosphoproteome analysis of Drosophila melanogaster embryos.";
RL   J. Proteome Res. 7:1675-1682(2008).
RN   [13]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=29746464; DOI=10.1371/journal.pbio.2005687;
RA   Seller C.A., O'Farrell P.H.;
RT   "Rif1 prolongs the embryonic S phase at the Drosophila mid-blastula
RT   transition.";
RL   PLoS Biol. 16:E2005687-E2005687(2018).
CC   -!- FUNCTION: Serine/threonine protein kinase which activates checkpoint
CC       signaling upon genotoxic stresses such as ionizing radiation (IR),
CC       ultraviolet light (UV), or DNA replication stalling, thereby acting as
CC       a DNA damage sensor. Recognizes the substrate consensus sequence [ST]-
CC       Q. Phosphorylates various proteins, which collectively inhibits DNA
CC       replication and mitosis and promotes DNA repair and recombination.
CC       Phosphorylates grp/CHK1. Phosphorylates 'Ser-137' of histone variant
CC       H2AX/H2AV at sites of DNA damage, thereby regulating DNA damage
CC       response mechanism. Essential for the DNA damage checkpoint in larval
CC       imaginal disks and neuroblasts and for the DNA replication checkpoint
CC       in the embryo. Has also an essential role during early nuclear
CC       divisions in embryos, where it is required to delay mitosis in response
CC       to incomplete DNA replication. Also plays an important role during
CC       meiosis, where it may monitor double-strand-break repair during meiotic
CC       crossing over, to regulate the progression of prophase I, and to
CC       enforce metaphase I delay observed at the end of oogenesis.
CC       {ECO:0000269|PubMed:10209095, ECO:0000269|PubMed:11676920,
CC       ECO:0000269|PubMed:12361566, ECO:0000269|PubMed:12689597,
CC       ECO:0000269|PubMed:14711410, ECO:0000269|PubMed:7671309}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250};
CC   -!- SUBUNIT: Interacts with mus304. {ECO:0000269|PubMed:14729967}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- DEVELOPMENTAL STAGE: Expressed both maternally and zygotically.
CC       {ECO:0000269|PubMed:10209095}.
CC   -!- DISRUPTION PHENOTYPE: In embryos, during S phase of mid-blastula
CC       transition, fails to delay the activation of Cdk1, leads to loss of
CC       Rif1 foci, and results in cells entering prematurely into mitosis 13
CC       before the completion of replication resulting in chromosome bridging.
CC       {ECO:0000269|PubMed:29746464}.
CC   -!- SIMILARITY: Belongs to the PI3/PI4-kinase family. ATM subfamily.
CC       {ECO:0000305}.
CC   -!- CAUTION: Called dATM in some references while it is the ortholog of
CC       ATR. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC46881.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U34925; AAC46881.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AY282465; AAQ22732.1; -; mRNA.
DR   EMBL; AE014298; AAF48604.2; -; Genomic_DNA.
DR   PIR; T13288; T13288.
DR   RefSeq; NP_523369.2; NM_078645.3.
DR   AlphaFoldDB; Q9VXG8; -.
DR   SMR; Q9VXG8; -.
DR   BioGRID; 58948; 34.
DR   IntAct; Q9VXG8; 4.
DR   STRING; 7227.FBpp0074047; -.
DR   iPTMnet; Q9VXG8; -.
DR   PaxDb; Q9VXG8; -.
DR   PRIDE; Q9VXG8; -.
DR   EnsemblMetazoa; FBtr0074271; FBpp0074047; FBgn0004367.
DR   GeneID; 32608; -.
DR   KEGG; dme:Dmel_CG4252; -.
DR   CTD; 32608; -.
DR   FlyBase; FBgn0004367; mei-41.
DR   VEuPathDB; VectorBase:FBgn0004367; -.
DR   eggNOG; KOG0890; Eukaryota.
DR   GeneTree; ENSGT00940000155714; -.
DR   HOGENOM; CLU_000178_1_0_1; -.
DR   InParanoid; Q9VXG8; -.
DR   OMA; YTVYSQM; -.
DR   OrthoDB; 80538at2759; -.
DR   PhylomeDB; Q9VXG8; -.
DR   Reactome; R-DME-176187; Activation of ATR in response to replication stress.
DR   Reactome; R-DME-5693607; Processing of DNA double-strand break ends.
DR   Reactome; R-DME-6804756; Regulation of TP53 Activity through Phosphorylation.
DR   Reactome; R-DME-69473; G2/M DNA damage checkpoint.
DR   SignaLink; Q9VXG8; -.
DR   BioGRID-ORCS; 32608; 0 hits in 3 CRISPR screens.
DR   GenomeRNAi; 32608; -.
DR   PRO; PR:Q9VXG8; -.
DR   Proteomes; UP000000803; Chromosome X.
DR   Bgee; FBgn0004367; Expressed in egg cell and 11 other tissues.
DR   ExpressionAtlas; Q9VXG8; baseline and differential.
DR   Genevisible; Q9VXG8; DM.
DR   GO; GO:0005634; C:nucleus; ISS:FlyBase.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISS:FlyBase.
DR   GO; GO:0007349; P:cellularization; TAS:FlyBase.
DR   GO; GO:0030261; P:chromosome condensation; IGI:FlyBase.
DR   GO; GO:0000077; P:DNA damage checkpoint signaling; IMP:FlyBase.
DR   GO; GO:0000076; P:DNA replication checkpoint signaling; IMP:FlyBase.
DR   GO; GO:0006302; P:double-strand break repair; IMP:FlyBase.
DR   GO; GO:0045002; P:double-strand break repair via single-strand annealing; IMP:FlyBase.
DR   GO; GO:0045003; P:double-strand break repair via synthesis-dependent strand annealing; IMP:FlyBase.
DR   GO; GO:0001700; P:embryonic development via the syncytial blastoderm; TAS:FlyBase.
DR   GO; GO:0016321; P:female meiosis chromosome segregation; IMP:FlyBase.
DR   GO; GO:0007444; P:imaginal disc development; TAS:FlyBase.
DR   GO; GO:0000706; P:meiotic DNA double-strand break processing; IDA:FlyBase.
DR   GO; GO:0033314; P:mitotic DNA replication checkpoint signaling; IMP:FlyBase.
DR   GO; GO:0030716; P:oocyte fate determination; IMP:FlyBase.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; ISS:FlyBase.
DR   GO; GO:0006468; P:protein phosphorylation; IMP:FlyBase.
DR   GO; GO:0007131; P:reciprocal meiotic recombination; IMP:FlyBase.
DR   GO; GO:1901990; P:regulation of mitotic cell cycle phase transition; IMP:UniProtKB.
DR   GO; GO:0007088; P:regulation of mitotic nuclear division; IMP:UniProtKB.
DR   GO; GO:0007348; P:regulation of syncytial blastoderm mitotic cell cycle; TAS:FlyBase.
DR   GO; GO:0009314; P:response to radiation; TAS:FlyBase.
DR   GO; GO:0000723; P:telomere maintenance; IGI:FlyBase.
DR   Gene3D; 1.10.1070.11; -; 1.
DR   Gene3D; 1.25.10.10; -; 1.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR003152; FATC_dom.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000403; PI3/4_kinase_cat_dom.
DR   InterPro; IPR036940; PI3/4_kinase_cat_sf.
DR   InterPro; IPR018936; PI3/4_kinase_CS.
DR   InterPro; IPR003151; PIK-rel_kinase_FAT.
DR   InterPro; IPR014009; PIK_FAT.
DR   InterPro; IPR012993; UME.
DR   Pfam; PF02259; FAT; 1.
DR   Pfam; PF02260; FATC; 1.
DR   Pfam; PF00454; PI3_PI4_kinase; 1.
DR   Pfam; PF08064; UME; 1.
DR   SMART; SM01343; FATC; 1.
DR   SMART; SM00146; PI3Kc; 1.
DR   SMART; SM00802; UME; 1.
DR   SUPFAM; SSF48371; SSF48371; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51189; FAT; 1.
DR   PROSITE; PS51190; FATC; 1.
DR   PROSITE; PS00916; PI3_4_KINASE_2; 1.
DR   PROSITE; PS50290; PI3_4_KINASE_3; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Developmental protein; DNA damage; DNA repair; DNA-binding;
KW   Kinase; Manganese; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..2517
FT                   /note="Serine/threonine-protein kinase ATR"
FT                   /id="PRO_0000225630"
FT   REPEAT          1178..1214
FT                   /note="HEAT"
FT   DOMAIN          1509..2066
FT                   /note="FAT"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00534"
FT   DOMAIN          2184..2508
FT                   /note="PI3K/PI4K catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00269"
FT   DOMAIN          2485..2517
FT                   /note="FATC"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00534,
FT                   ECO:0000255|PROSITE-ProRule:PRU00535"
FT   REGION          2190..2196
FT                   /note="G-loop"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00269"
FT   REGION          2360..2368
FT                   /note="Catalytic loop"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00269"
FT   REGION          2380..2404
FT                   /note="Activation loop"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00269"
FT   MOD_RES         1569
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:18327897"
FT   MOD_RES         1570
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000269|PubMed:18327897"
FT   MOD_RES         1573
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:18327897"
FT   MOD_RES         1575
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:18327897"
FT   MUTAGEN         253
FT                   /note="W->T: In mei-41D12; induces a weak sensitivity to
FT                   methanesulfonate."
FT                   /evidence="ECO:0000269|PubMed:12807779"
FT   MUTAGEN         647
FT                   /note="A->V: In mei-41D3; induces a very strong sensitivity
FT                   to methanesulfonate and female infertility."
FT                   /evidence="ECO:0000269|PubMed:12807779"
FT   MUTAGEN         810
FT                   /note="S->F: In mei-41D9; induces some sensitivity to
FT                   methanesulfonate."
FT                   /evidence="ECO:0000269|PubMed:12807779"
FT   MUTAGEN         815
FT                   /note="T->P: In mei-41D15; induces some sensitivity to
FT                   methanesulfonate."
FT                   /evidence="ECO:0000269|PubMed:12807779"
FT   MUTAGEN         818
FT                   /note="L->F: In mei-41D14; induces some sensitivity to
FT                   methanesulfonate."
FT                   /evidence="ECO:0000269|PubMed:12807779"
FT   MUTAGEN         2032
FT                   /note="H->Y: In mei-41D12; induces a weak sensitivity to
FT                   methanesulfonate."
FT                   /evidence="ECO:0000269|PubMed:12807779"
FT   MUTAGEN         2322
FT                   /note="P->L: In mei-41D5; induces a strong sensitivity to
FT                   methanesulfonate."
FT                   /evidence="ECO:0000269|PubMed:12807779"
FT   CONFLICT        22
FT                   /note="N -> I (in Ref. 1)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        338
FT                   /note="M -> L (in Ref. 1; AAC46881)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        345
FT                   /note="H -> Y (in Ref. 1; AAC46881)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        392
FT                   /note="L -> M (in Ref. 1; AAC46881)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        461
FT                   /note="R -> Q (in Ref. 1; AAC46881)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        502
FT                   /note="Y -> H (in Ref. 1; AAC46881)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        568
FT                   /note="S -> G (in Ref. 1; AAC46881)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        713
FT                   /note="T -> A (in Ref. 1; AAC46881)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1125
FT                   /note="N -> D (in Ref. 1; AAC46881)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1350
FT                   /note="R -> K (in Ref. 1; AAC46881)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   2517 AA;  289330 MW;  8ABE2499EA477B88 CRC64;
     MSTQRKDMWK LLYNHVNRNV SNFSGVYSVI EDILCQEPSL ISCSLVRELH NKFQDTFLLW
     LLNKLAKCLS ESPDSSECIN LQRKILSSCC SNHPKLFERL VLAYVEAIEE THLQLSSLDL
     GQLSNERKPA ITVRIFRCDV ECLQEFDPHC AIEDIKVPLE QADMYAKSLL EVLQHAHHIG
     YATHGDIFSG SLHQALLILK ECDMDTKLAS LNYCHNVLRS QSASSWITNP DVGHYAQLTL
     EATAIMWSAV AKWLDMGCMT RQELKRLNIT TKLLLEVLHM RARPAHHLGY LLLNEILSLP
     TAIELDDGLL ETLSSYIQGQ LEHSVVPLEQ LVHLQQLMLS HWHCHPTHLV PILALMGLKQ
     TEMRSGVVQV LTQSLVEILK KEEVLSKDWQ KLIAILRGFK QLEKLILSQS QHKIAEHEGH
     IDSSVLAMLP LQCEIIKVAD TNWNNLSMQL VELESKCSAD RRHIHLEICS LLMQITFIRH
     FLKTQTQHQL LAILQRHLKL SYLCAIRLET PSSVHTQMQS FYAQQYMRLF QSEETQEIFC
     SNLPQLYISG FIKPEQLMKA LPTINNRSGR AQVIRLLLCS QPGKLSVFKV KDRIELYCPK
     CRPLPKKLPG IYLGKCKQQL PCPDFSSTNL EMIANDLLFY PDFECIAQHL DLLCFEPNVI
     LGLLRETEAL QKVSVKVIGQ LVSAMRVRSP EFLEQLANLV LAAIKAMLAK PLTEQNVLQQ
     RSMLNVLTAI AHMEDNEIWL FHWFKMTFFF LVHTRSLVAQ EAVLAATEMC ASQGLQTIHL
     WNWYKRDALD LTVRLALNVY LLDGVRFTRS LRALTKMLGF TCVQEFTCKY HRLLTAMVLP
     HCIVNPLCKG VLVLIAKQMQ KHIGTLFSIS FLRIYTHVFL TEEPELANSC IELVVSCTQS
     SLQQLMNADV KQTVAELLIY FNRNPTFVMR SFQSLLQLSI GSLEELSSQT ANAEFANFIA
     ERFLGVITYF ESCLSEPSFE KPLKEETLYS LGQIMRFVGS QHVTQFRFKI IAMLSFVHTL
     QEPRLQRICL KIWHIFLHVV NVQELGPSLG RIVATLQPLL ADNESVKQVN DLYEFIILRN
     ASMLGTFITD LYFLDRMENV SPSIQKCIRR HTAHLDLKGL AEEENQSPPL VDQLRFLQKH
     ITDECLQVRV YALQHLGDLF GRRRPKLNST ILSELPLEPM LEQIVNVLMA GCQHDDSQLQ
     MASAKCLGEL GAIDASYLPS NYNFASPQHL PLNILSDDFA VLALTSLCRG YQFQQNTKHV
     DSFSLAIQET LAICGISPKE QKKVQLWQSL PARMRQLMEP MLHSCYTCVH RPSTCLQQPL
     FGSHYSHNYY EEWAFLWASR LIDYLPSSGR RHLLSSYKPC IKRDSNMLST FYPYILLHAL
     LECTTEQRNH IQEEFMAVLQ ANEESSSSVR GRQELGAIKE NAFKQFESRK YAAGIKPLAS
     TLVSDRKEDS SRVPRLAGKL CAELLDFLQR WLREWQRIHG RSTGGKPPET IDSNYRKIHE
     FLNLIPKLLV SRASYNCGEY ARALSYLESY LEEGEDKSQR LLEQFTFLVE VYGSLRDPDS
     VEGAVQVRSY DMSVTQDILV NRLVERQQDM ITSYEQLLSS TDQMQPDHVR AMIDAYLRDT
     PKTAQLIADG LWQRLSDRYS DQCFAECKSE LLWRLGSYDE MEELQSNWPA QCSQGCLKLR
     RPLTTRIEFD SLLDGMRESV LEELRSCSAV QQHSYANAYD AVLKLHLVHE LHCSQELVEK
     LEQDRDEDNQ EKLMKNYFDD WQYRLQIVQP QVRIQESIYS FRRNILAELQ RRLTDRNHLL
     PHLKTELARI WLNSAQINRN AGQLQRAQLY ILKAAEYQPS GLFIERAKLL WQKGDQVMAM
     NYLEEQLSIM RSGCQGNVKQ LAAEQRHLFF RGKYLQAVYS AESMHLCADA VLKYFQEAIA
     VHRQSESCHV QMAQFLEKIL EARQGGKSEP TGEQDDMLIN VMVNYAKSLR YGSEHVYQSM
     PRLISLWLDT TESSTNTEQV KKMNDLLTNC CTALPTAVFY TVYSQMLSRL CHPVNDVFTV
     LRNVIIKLVE AYPQQSLWML LPHFKSAKAH RIKRCKLVLT DSRLQNSTFQ KLLQDFNSLT
     ERLMDLTNKE VTLDRTYKLS DLDTRLSKLC KQPEFSQILL PFEKYMQPTL PLNSDSNSSE
     GSHLPANQST VNWFPYQQIY ISGFQESVLI LRSAAKPKKL TIRCSDGKDY DVLVKPKDDL
     RRDARLMEFN GLVKRYLHQD APARQRRLHI RTYAVLPFNE ECGLVEWLPN LASYRSICMN
     LYAQRRLVMS TRQLQSLAVP LHESIERKRE VFTKQLVPAH PPVFQEWLRQ RFATPHSWYE
     ARNTYIRTVA VMSMVGYILG LGDRHGENIL FAEGNGDAVH VDFNCLFNQG ELLPYPEVVP
     FRLTHNMIVA MGPLGVEGSF RKCCEITLRL LKQESKTLMS ILRPFVYDVG AQTRKGAATA
     KITKDVQRIA DRLQGHVKRQ QANSIPLSTE GQVNFLINEA TKVDNLASMY IGWGAFL
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024